Pfizer (PFE) PT Lowered to $36 at JPMorgan
Get Alerts PFE Hot Sheet
Price: $27.75 -0.11%
Rating Summary:
13 Buy, 20 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 0
Rating Summary:
13 Buy, 20 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 0
Join SI Premium – FREE
JPMorgan analyst Chris Schott lowered the price target on Pfizer (NYSE: PFE) to $36.00 (from $37.00) while maintaining a Neutral rating.
The analyst comments "We see a clear inflection in growth for Pfizer after the Lyrica patent expiration in 2019 with a reacceleration of the company’s organic top- and bottom-line growth in the 2020-2025 period (top-line growth of ~5% expected to be above Major Pharma). However, we remain Neutral with valuation reflecting visible near-term growth and another major patent cycle post-2025."
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Hyundai Motor (005380:KS) (HYMTF) PT Raised to KRW290 at Citi
- Charter Communications (CHTR) PT Lowered to $325 at UBS
- Dollar General (DG) PT Raised to $175 at Argus
Create E-mail Alert Related Categories
Analyst Comments, Analyst PT Change, Hot CommentsRelated Entities
JPMorganSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!